novo nordisk weight loss drug news - Search News

Novo Nordisk faces stock market bloodbath

Retail investors buy Novo dip after disappointing weight-loss drug data

U.S. retail investor fund flows into Novo Nordisk surged 32-fold on Friday, as the Danish drugmaker's weaker-than-expected obesity drug data offered a rare dip-buying opportunity, according to Vanda Research.

Hosted on MSN · 4d

Novo Nordisk faces stock market bloodbath after weight-loss drug trial disappoints

Novo Nordisk, Europe’s largest company by market value, faced a stock market bloodbath on Friday after disappointing results from a new drug study caused investors to flee the drugmaker. The Danish producer of Ozempic,

Markets Insider on MSN · 4d

Novo Nordisk stock plunges 20% after a trial of its latest weight loss drug disappoints

The Ozempic maker's stock tanked after its highly anticipated CagriSema drug trial showed an average of 22.7% weight loss, below expectations for 25%.

5h

Off-brand versions of Lilly weight loss drug must be pulled off market, could mean higher prices

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

6don MSN

Ozempic Dethroned? A Head-to-Head Study Confirms This Company Has the Best Weight Loss Drug

But in an increasingly competitive market for weight loss drugs, these are not the only options for people looking to lose ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results